Bexion Pharmaceuticals, Inc. Announces First Patient Dosed with BXQ-350 in the RETRO Clinical Study

/PRNewswire/ -- Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biologics for the treatment of cancer and neuropathy,...

Related Keywords

Ohio ,United States ,Cincinnati ,Margaret Van Gilse ,Scott Shively ,Prnewswire Bexion Pharmaceuticals Inc ,Bexion Pharmaceuticals ,Bexion Pharmaceuticals Inc ,Clinical Research Center ,Study Aims ,Assess Potential ,Prevalent Limitation ,Pilot Proof ,Cancer Patients ,Chief Executive Officer ,Research Center ,Glioblastoma Multiforme ,Nc ,